Associated Papers
Real-World Efficacy and Safety of PARP Inhibitors in Recurrent Ovarian Cancer Patients With Somatic BRCA and Other Homologous Recombination Gene Mutations.
Pan YE et al.
The Annals of Pharmacotherapy, 2023
ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis.
Yachida N et al.
Scientific Reports, 2020
32868822 (PubMed )
Supplement: 41598_2020_71273_MOESM1_ESM.docx
Select a paper to view details